問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2019-04-15 - 2021-10-31
Condition/Disease
Resected Pancreatic Cancer
Test Drug
TS-1® (S-1)
Participate Sites4Sites
Recruiting4Sites
2011-03-01 - 2015-12-31
Participate Sites5Sites
Terminated5Sites
2011-05-01 - 2012-06-30
Terminated4Sites
2006-02-01 - 2007-04-30
Participate Sites7Sites
Terminated7Sites
2007-07-02 - 2012-06-30
Participate Sites11Sites
Terminated11Sites
2009-07-01 - 2013-08-31
Participate Sites12Sites
Terminated12Sites
2007-02-01 - 2009-04-30
2014-11-01 - 2016-10-31
advanced biliary tract cancer
TS-1®
2015-06-30 - 2017-12-31
neutropenic
amphotericin B
Participate Sites10Sites
Terminated9Sites
Division of Infectious Disease
2020-05-01 - 2023-05-01
Generalized Pustular Psoriasis
BI 655130 (Spesolimab)
Participate Sites3Sites
Not yet recruiting1Sites
Recruiting1Sites
Terminated1Sites
全部
